Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?

Despite recent therapeutic advances, pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, with remarkable resistance to treatment, poor prognosis, and poor clinical outcome. More efficient therapeutic approaches are urgently needed to improve patients’ survival. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereti, Evangelia, Papapostolou, Irida, Dimas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046065/
https://www.ncbi.nlm.nih.gov/pubmed/36979869
http://dx.doi.org/10.3390/biomedicines11030890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046065/
https://www.ncbi.nlm.nih.gov/pubmed/36979869
http://dx.doi.org/10.3390/biomedicines11030890

Ejemplares similares